Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Tanabe to Continue Strategic Technical Alliances with Foreign Companies
December 24, 2001
- Sysmex Develops Hemocytometer for POC Use
December 24, 2001
- 33 JPMA Member Companies: Sales Up 2.4%, Profits Up 56.5%
December 24, 2001
- Pharmacia to Spin Off Stake in Monsanto
December 24, 2001
- Morishita Jintan: Sales Up 3.7%, Net Profits Plummet
December 24, 2001
- Sysmex to Make International Reagents Its 100%-owned Subsidiary
December 24, 2001
- JCR Pharmaceutical: Sales Down 9.0%, Profits Down 45.1%
December 24, 2001
- Arkray Adds Gastric Cancer as Test Item to Home Health Check
December 24, 2001
- Both Income, Expenses Decreased at Clinics
December 24, 2001
- Re-pricing Rule to Be Introduced for Medical Materials
December 24, 2001
- Medical Facilities Obtain Great Profits with Small Capital: Kenporen Study
December 24, 2001
- Iatron Develops New Reagent to Determine Blood Elastase-1
December 24, 2001
- Tanabe's Remicade Approved for Crohn: CDFS
December 24, 2001
- Oxford GlycoSciences Hoping to Form Japanese Alliances
December 24, 2001
- Panel Recommends On-line Medical Billing
December 24, 2001
- REGULATORY NEWS IN BRIEF
December 24, 2001
- Vital-Net Aims at Sales Per MS of \150 million in FY2003
December 24, 2001
- Number of Clinical Trial Protocols Submitted Remains Flat: Korosho
December 24, 2001
- FALCO Biosystems Certified by CAP
December 24, 2001
- GL on Stroke Treatment Under Preparation: Seminar
December 24, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…